INS and type 2 diabetes mellitus: GLP-1 is secreted in response to nutrients and its levels are decreased in type 2 diabetes; it acts stimulating glucose-dependent insulin release from the pancreatic islets and this is the major advantage over sulfonylureas, as it prevents hypoglycaemia [47].